Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Catalyst Pharmaceuticals Shares Outstanding 2010-2025 | CPRX

Catalyst Pharmaceuticals shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Catalyst Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2024 125
2023 114
2022 111
2021 108
2020 106
2019 106
2018 103
2017 86
2016 83
2015 81
2014 64
2013 45
2012 30
2011 22
2010 19
2009 15
Catalyst Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 127
2024-12-31 125
2024-09-30 125
2024-06-30 125
2024-03-31 123
2023-12-31 114
2023-09-30 107
2023-06-30 114
2023-03-31 114
2022-12-31 111
2022-09-30 112
2022-06-30 109
2022-03-31 109
2021-12-31 108
2021-09-30 108
2021-06-30 108
2021-03-31 107
2020-12-31 106
2020-09-30 106
2020-06-30 107
2020-03-31 107
2019-12-31 106
2019-09-30 107
2019-06-30 106
2019-03-31 103
2018-12-31 103
2018-09-30 103
2018-06-30 103
2018-03-31 103
2017-12-31 86
2017-09-30 85
2017-06-30 84
2017-03-31 83
2016-12-31 83
2016-09-30 83
2016-06-30 83
2016-03-31 83
2015-12-31 81
2015-09-30 82
2015-06-30 82
2015-03-31 76
2014-12-31 64
2014-09-30 67
2014-06-30 66
2014-03-31 54
2013-12-31 45
2013-09-30 45
2013-06-30 41
2013-03-31 41
2012-12-31 30
2012-09-30 32
2012-06-30 27
2012-03-31 25
2011-12-31 22
2011-09-30 22
2011-06-30 22
2011-03-31 20
2010-12-31 19
2010-09-30 19
2010-06-30 18
2010-03-31 18
2009-12-31 15
2009-09-30 14
2009-06-30 14
2009-03-31 14
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.850B $0.492B
Catalyst Pharmaceuticals, Inc. is a development-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders, like Lambert-Eaton Myasthenic Syndrome (LEMS), epilepsy and Tourette syndrome. Catalyst in-licensed rights to Firdapse (for treating LEMS) from BioMarin Pharmaceutical Inc. for its development and commercialization in the U.S. Firdapse is currently approved in the European Union and in the U.S. for treating of LEMS in adults. The company also plans to file a supplemental new drug application for Firdapse to treat pediatric patients with LEMS.?The company is also strengthening the commercial portfolio of Firdapse. It has already received multiple patents that cover the treatment of all amifampridine metabolizer types within the LEMS patient population.?Apart from Firdapse, the company is working on a generic version of Lundbeck's Sabril, CPP-109, for the treatment of infantile spasms and complex partial seizures.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $92.840B 34.83
Zoetis (ZTS) United States $70.908B 26.46
Daiichi Sankyo, - (DSNKY) Japan $46.582B 23.70
Takeda Pharmaceutical (TAK) Japan $45.692B 9.09
Sandoz Group AG (SDZNY) Switzerland $20.090B 0.00
Merck (MKKGY) Germany $17.991B 14.89
Summit Therapeutics (SMMT) United States $17.794B 0.00
Shionogi (SGIOY) Japan $14.019B 14.05
United Therapeutics (UTHR) United States $13.596B 12.03
Neurocrine Biosciences (NBIX) United States $11.451B 39.22
IPSEN (IPSEY) France $9.860B 0.00
Orion OYJ (ORINY) Finland $8.661B 23.42
Corcept Therapeutics (CORT) United States $7.448B 60.54
Stevanato Group S.p.A (STVN) Italy $7.268B 44.44
Madrigal Pharmaceuticals (MDGL) United States $6.542B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.134B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Grifols, S.A (GRFS) Spain $4.882B 0.00
Soleno Therapeutics (SLNO) United States $3.869B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.873B 0.00
Hypermarcas (HYPMY) Brazil $2.486B 16.35
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.297B 12.56
BioCryst Pharmaceuticals (BCRX) United States $2.086B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.017B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.741B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
Guardian Pharmacy Services (GRDN) United States $1.622B 0.00
Indivior (INDV) United States $1.528B 6.48
Evotec AG (EVO) Germany $1.527B 0.00
ARS Pharmaceuticals (SPRY) United States $1.320B 168.00
Dyne Therapeutics (DYN) United States $1.297B 0.00
Ocular Therapeutix (OCUL) United States $1.125B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 44.44
Collegium Pharmaceutical (COLL) United States $0.928B 5.01
Avadel Pharmaceuticals (AVDL) Ireland $0.907B 0.00
Enliven Therapeutics (ELVN) United States $0.904B 0.00
Harrow (HROW) United States $0.895B 0.00
Ardelyx (ARDX) United States $0.866B 0.00
Xeris Biopharma Holdings (XERS) United States $0.783B 0.00
Cronos Group (CRON) Canada $0.763B 0.00
AleAnna (ANNA) United States $0.732B 0.00
Akebia Therapeutics (AKBA) United States $0.668B 0.00
Xencor (XNCR) United States $0.593B 0.00
KalVista Pharmaceuticals (KALV) United States $0.592B 0.00
USANA Health Sciences (USNA) United States $0.549B 11.94
Bioventus (BVS) United States $0.547B 13.92
Regulus Therapeutics (RGLS) United States $0.521B 0.00
Relay Therapeutics (RLAY) United States $0.514B 0.00
CytoDyn (CYDY) United States $0.497B 0.00
Savara (SVRA) United States $0.494B 0.00
Elite Pharmaceuticals (ELTP) United States $0.469B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.449B 0.00
Altimmune (ALT) United States $0.431B 0.00
Zevra Therapeutics (ZVRA) United States $0.430B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.411B 0.00
Siga Technologies (SIGA) United States $0.404B 8.45
Organogenesis (ORGO) United States $0.388B 0.00
Tourmaline Bio (TRML) United States $0.388B 0.00
Verve Therapeutics (VERV) United States $0.377B 0.00
Oruka Therapeutics (ORKA) United States $0.357B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.07
Heron Therapeutics (HRTX) United States $0.322B 0.00
Aquestive Therapeutics (AQST) United States $0.277B 0.00
Nature's Sunshine Products (NATR) United States $0.253B 23.39
ProKidney (PROK) United States $0.211B 0.00
Wellgistics Health (WGRX) United States $0.195B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Avita Medical (RCEL) United States $0.184B 0.00
OmniAb (OABI) United States $0.176B 0.00
Nanobiotix S.A (NBTX) France $0.161B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Esperion Therapeutics (ESPR) United States $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.146B 0.00
4D Molecular Therapeutics (FDMT) United States $0.143B 0.00
Profound Medical (PROF) Canada $0.139B 0.00
Aclaris Therapeutics (ACRS) United States $0.136B 0.00
Larimar Therapeutics (LRMR) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.112B 0.00
Nektar Therapeutics (NKTR) United States $0.110B 0.00
VAXART, INC (VXRT) United States $0.096B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.089B 0.00
Dominari Holdings (DOMH) United States $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.086B 14.14
Cassava Sciences (SAVA) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Achieve Life Sciences (ACHV) Canada $0.082B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.066B 52.22
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Prelude Therapeutics (PRLD) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Surrozen (SRZN) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
DURECT (DRRX) United States $0.023B 0.00
Mannatech (MTEX) United States $0.021B 8.31
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Plus Therapeutics (PSTV) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00